Quantitative Assessment of Shoulder Proprioception in Patients With Chronic Mechanical Cervical Pain
Launched by HAMADA AHMED · Feb 7, 2020
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
The study was aimed to compare shoulder proprioception in chronic mechanical cervical pain to a matched normal group. This study include two groups, 40 subjects with mechanical chronic cervical pain and 40 healthy subjects representing the control group. The primary outcome measure was the shoulder proprioception test of both upper limbs during active repositioning and quantified with angular displacement error. Test was applied using an isokinetic dynamometer device at angle 30° for both shoulder internal and external rotation on both sides with an angular velocity 30°/sec.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The age ranged from 20 to 35 years.
- • Body Mass Index (BMI) between 18 and less than 30.
- • Sufficient cognitive abilities that enables them to understand and follow instructions with a score more than 24 in the Mini-Mental State Examination (MMSE) scale.
- • For the group with cervical pain, participants had a chronic mechanical cervical pain started from three to 12 months.
- • Participants with chronic pain with a score of 3 to 65 according to the short-form of the McGill Pain Questionnaire (SF-MPQ).
- Exclusion Criteria:
- • Shoulder problems.
- • Previous cervical or shoulder surgery.
- • Shoulder or cervical trauma.
- • Cervical radiculopathy.
- • Sever visual and/or auditory problems.
- • Cognitive impairment (a score less than 24 according to MMSE).
About Hamada Ahmed
Hamada Ahmed is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and evidence-based practices, Ahmed oversees the design, implementation, and management of clinical trials across various therapeutic areas. Leveraging a deep understanding of regulatory requirements and a collaborative approach, he fosters partnerships with healthcare professionals and research institutions to ensure the highest standards of safety and efficacy in trial execution. His leadership is characterized by a commitment to ethical practices and the pursuit of scientific excellence, driving progress in the field of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, Cairo, Egypt
Patients applied
Trial Officials
Wael Shendy, PhD
Study Director
Associate professor Faculty of Physical Therapy-Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials